Humira Drug Insights 2017 Report Updated 10072017 Prices from USD $1000
DelveInsight's pharmaceuticals report Humira Drug Insights 2017 highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers...
View ArticleCrohn's & Colitis Foundation Launches New IBD Clinical Trials Community to...
NEW YORK July 20 2017 PRNewswireUSNewswire Clinical trial recruitment is a challenging step toward FDA approval of new treatments for patients across all disease states; this is especially true for...
View ArticleLitmus Health Announces Advisory Board as RealLife Data Gain Traction in...
James Crooks PhD promoted to Chief Technology OfficerAUSTIN TX PRWEB July 20 2017 Litmus Health a clinical data science platform focused on healthrelated quality of life today announced its full...
View ArticleCrohn's & Colitis Foundation Launches New IBD Clinical Trials Community To...
Life Sciences Jobs ...
View ArticleGlobal PEGylated Proteins Market 2012 2022 Report Updated 01042017 Prices...
SummaryBased on products type the report describes major products type share of regional market. Products mentioned as follows By Type Colony Stimulating Factors Interferons Erythropoietin EPO...
View ArticleMezavant Xl API Insights 2017 Report Updated 10072017 Prices from USD $500
DelveInsight's Mezavant Xl API Insights 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF...
View ArticleCimzia Drug Insights 2017 Report Updated 10072017 Prices from USD $1000
DelveInsight's pharmaceuticals report Cimzia Drug Insights 2017 highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers...
View ArticleMerck Announces U.S. Launch of RENFLEXIS infliximababda a Biosimilar of...
Merck NYSEMRK known as MSD outside the United States and Canada today announced the U.S. launch of RENFLEXIS infliximababda a biosimilar of the originator biologic medicine Remicade infliximab....
View ArticleSamsung Bioepis Announces RENFLEXIS infliximababda Now Available in the...
RENFLEXIS infliximababda is the first drug developed by Samsung Bioepis to launch in the United States following the US Food and Drug Administrations April 2017 approval RENFLEXIS a biosimilar ...
View ArticleSTAT Plus Pharmalittle Merck launches a biosimilar Remicade; J&J releases...
Merck and Samsung Bioepsis launched a biosimilar version of Remicade in the U.S. for treating rheumatoid arthritis and Crohn's disease.
View ArticleAbbVie Inc ABBV Pharmaceuticals Healthcare Deals and Alliances Profile....
SummaryAbbVie Inc AbbVie is a researchbased biopharmaceutical company that carries out the research development manufacture and commercialization of advanced therapies to treat complex and serious...
View ArticleArena Pharmaceuticals Inc ARNA Pharmaceuticals Healthcare Deals and Alliances...
SummaryArena Pharmaceuticals Inc Arena is a biopharmaceutical company which discovers develops and commercializes small molecule drugs in multiple therapy areas. Its pipeline portfolio encompasses...
View ArticleAcibadem Saglik Hizmetleri ve Ticaret AS Pharmaceuticals Healthcare Deals and...
SummaryAcibadem Saglik Hizmetleri ve Ticaret AS Acibadem is a healthcare service provider that provides diagnosis and treatment services. The center provides aesthetic plastic and reconstructive...
View ArticleCrohns & Colitis Foundation launches IBD Clinical Trials Community
Clinical trial recruitment is a challenging step toward FDA approval of new treatments for patients across all disease states; this is especially true for inflammatory bowel diseases IBD.ÂThe...
View ArticleKezar Life Sciences Announces Successful Completion of Phase 1a Study and...
SOUTH SAN FRANCISCO Calif. July 25 2017 PRNewswire Kezar Life Sciences a private clinicalstage biopharmaceutical company developing novel small molecule therapeutics targeting the immunoproteasome and...
View ArticleUT Southwestern finds link between backup immune defense mutation seen in...
UT Southwestern Medical Center Genes that regulate a cellular recycling system called autophagy are commonly mutated in Crohn's disease patients though the link between biological housekeeping and...
View ArticleValeant Announces U.S. Launch of SILIQ brodalumab Injection
Dermatology Unit Is Rebranded Ortho Dermatologics LAVAL Quebec July 27 2017 PRNewswire Valeant Pharmaceuticals International Inc. NYSE VRX and TSX VRX today announced the launch of SILIQ brodalumab...
View ArticleSoligenix Initiates Pivotal Phase 3 Clinical Trial of SGX942 Dusquetide for...
PRINCETON N.J. July 27 2017 PRNewswire Soligenix Inc. Nasdaq SNGX Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to treat rare...
View ArticleBiotech Players Lead the Growth Charge in the Legal Cannabis Market
NEW YORK July 27 2017 PRNewswire The backbone of medical advancement is biotechnology an industry wrought with the incredible potential of novel drug R&D but vulnerable to the risk of stringent...
View ArticleNational Association of Specialty Pharmacy NASP 5th Annual Conference Keynote...
WASHINGTON July 27 2017 PRNewswire Pharmaceutical executive healthcare industry leader and former president of Lilly USA Alex Azar will kick off the fifth annual National Association of Specialty...
View Article